SCHEMBL31362884

SCHEMBL31362884

Cc1ccc(S(=O)(=O)OCC(F)CC2COC(C)(C)N2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.36
BRD4 O60885 1/20 0.35
MMP13 P45452 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
P2RX7 Q99572 2/20 0.34
HSD11B2 P80365 1/20 0.33
GPR119 Q8TDV5 3/20 0.32
TSHR P16473 3/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
GAA P10253 1/20 0.31
RORC P51449 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4346843 0.86 SPHK1 (0.40) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL2669188 0.86 SPHK1 (0.40) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL4346836 0.86 SPHK1 (0.40) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL2332163 0.85 SPHK1 (0.35) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL8240970 0.85 SPHK1 (0.33) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL2322323 0.85 ABCG2 (0.34) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL2332152 0.85 SPHK1 (0.35) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL2322332 0.85 ABCG2 (0.34) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL2332146 0.85 SPHK1 (0.35) SPHK1BRD4MMP13MEN1KMT2A
SCHEMBL2322328 0.85 ABCG2 (0.34) SPHK1BRD4MMP13MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066328-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2025-02-27 US disclosed
WO-2025024663-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2025-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066328-A1 PARP7 INHIBITORS PARP1, PARP2, PARP8 SPHK1 2346/4885BRD4 345/4885MMP13 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.